Stay updated on ERP Biomarkers in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the ERP Biomarkers in Schizophrenia Clinical Trial page.

Latest updates to the ERP Biomarkers in Schizophrenia Clinical Trial page
- Check4 days agoChange DetectedAdded related topics and study locations (California, New Jersey, New York) with revision v3.3.3; removed the old HHS Vulnerability Disclosure entry and older location entries.SummaryDifference0.6%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedSchizophrenia and related MedlinePlus Genetics topics were removed from the page, reducing access to context and related resources.SummaryDifference0.2%

- Check25 days agoChange DetectedAdded Schizophrenia as a topic and MedlinePlus Genetics to the related topics on the study page.SummaryDifference0.2%

- Check33 days agoChange DetectedA new Revision: v3.3.2 is shown, and references to Schizophrenia and related topics (including MedlinePlus Genetics) are removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check40 days agoChange Detected- Deleted the general operating status notice about a lapse in government funding from the page.SummaryDifference0.4%

- Check47 days agoChange DetectedThe page now shows related topics: Schizophrenia and MedlinePlus Genetics, added as navigation links rather than core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to ERP Biomarkers in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ERP Biomarkers in Schizophrenia Clinical Trial page.